Table 1.
APOA1 levels | Total patients | Patients with NAFLD | Prevalence rate | χ2 value | P value |
---|---|---|---|---|---|
Q1 | 3300 | 1075 | 32.58% | 292.109 | <0.001 |
Q2 | 3165 | 893 | 28.21% | ||
Q3 | 3156 | 680 | 21.55% | ||
Q4 | 3202 | 499 | 15.58% |
APOA1 levels | Total patients | Patients with NAFLD | Prevalence rate | χ2 value | P value |
---|---|---|---|---|---|
Q1 | 3300 | 1075 | 32.58% | 292.109 | <0.001 |
Q2 | 3165 | 893 | 28.21% | ||
Q3 | 3156 | 680 | 21.55% | ||
Q4 | 3202 | 499 | 15.58% |